Literature DB >> 15448916

[Eppendorf Schizophrenia Inventory (ESI) vs. Frankfurt Complaint Questionnaire (FCQ). Direct comparison in a clinical trial].

R Mass1.   

Abstract

UNLABELLED: This study is the first to directly compare two clinical questionnaires which are both aimed at self-experienced cognitive dysfunctions of schizophrenia: Eppendorf Schizophrenia Inventory (ESI) and Frankfurt Complaint Questionnaire (FCQ). Evaluated were (a) diagnostic validity, (b) psychometric properties, (c) scale intercorrelations, and (d) factor analytic stability. Ad (a): schizophrenic subjects (n=36) show highly significant increases in the ESI scales and sum score when compared to other clinical groups (patients with depression, alcohol dependence, or obsessive-compulsive disorder, n>30, respectively); on the other hand, the FCQ yields no systematic group differences. Ad (b): mean of reliability coefficients (Cronbach alpha) of the ESI scales is r(tt)=0.86, mean of reliability coefficients of the FCQ scales is significantly lower. Ad (c): the mean intercorrelation between ESI and FCQ scales amounts to r(xy)=0.56 (minimum 0.29, maximum 0.73), corresponding to an average shared variance of about 31%. Ad (d): factor analysis yielded an ESI factor and a FBF factor; one-way ANOVA with the factor scores confirms the diagnostic validity of the ESI.
CONCLUSIONS: ESI and FCQ measure essentially different aspects of schizophrenic psychopathology. Regarding reliability and diagnostic validity, the ESI is superior to the FCQ.

Entities:  

Mesh:

Year:  2005        PMID: 15448916     DOI: 10.1007/s00115-004-1809-1

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  17 in total

Review 1.  Ethics and early intervention in psychosis: keeping up the pace and staying in step.

Authors:  P D McGorry; A Yung; L Phillips
Journal:  Schizophr Res       Date:  2001-08-01       Impact factor: 4.939

2.  Early self-experienced neuropsychological deficits and subsequent schizophrenic diseases: an 8-year average follow-up prospective study.

Authors:  J Klosterkötter; F Schultze-Lutter; G Gross; G Huber; E M Steinmeyer
Journal:  Acta Psychiatr Scand       Date:  1997-05       Impact factor: 6.392

3.  [Schizophrenia specificity of negative and basic symptoms].

Authors:  C Mundt; S Kasper
Journal:  Nervenarzt       Date:  1987-08       Impact factor: 1.214

4.  The early symptoms of schizophrenia.

Authors:  J Chapman
Journal:  Br J Psychiatry       Date:  1966-03       Impact factor: 9.319

5.  [Substrate near-basic disorder or nosologically ambiguous subjective cognitive disorder? Critical analysis of the Frankfurt Complaint Questionnaire by Süllwold].

Authors:  L Teusch
Journal:  Nervenarzt       Date:  1985-05       Impact factor: 1.214

6.  [The vigilance paradigm in schizophrenia research - studies on the Continuous Performance Test (CPT)].

Authors:  R Mass
Journal:  Fortschr Neurol Psychiatr       Date:  2002-01       Impact factor: 0.752

7.  Abnormal subjective experiences in schizophrenia: its relationships with neuropsychological disturbances and frontal signs.

Authors:  M J Cuesta; V Peralta; J A Juan
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1996       Impact factor: 5.270

8.  Early signs of psychotic relapse in schizophrenia.

Authors:  P Jørgensen
Journal:  Br J Psychiatry       Date:  1998-04       Impact factor: 9.319

9.  Dimensional structure and diagnostic specificity of the Frankfurt Complaint Questionnaire.

Authors:  R Maβ; C Haasen; M Krausz
Journal:  Eur Psychiatry       Date:  1997       Impact factor: 5.361

10.  Subjective cognitive dysfunction, eye tracking, and slow brain potentials in schizophrenic and schizoaffective patients.

Authors:  R J van den Bosch; N Rozendaal
Journal:  Biol Psychiatry       Date:  1988-11       Impact factor: 13.382

View more
  1 in total

1.  The psychopathological and psychosocial outcome of early-onset schizophrenia: preliminary data of a 13-year follow-up.

Authors:  Andreas Reichert; Susanne Kreiker; Claudia Mehler-Wex; Andreas Warnke
Journal:  Child Adolesc Psychiatry Ment Health       Date:  2008-02-27       Impact factor: 3.033

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.